Understanding the molecular and cellular mechanisms of tumor biology can inform the development of targeted therapies. For instance, drugs that inhibit specific signaling pathways or genetic mutations can be designed to selectively kill cancer cells while sparing normal cells. Moreover, insights into the tumor microenvironment and immune evasion can lead to the development of immunotherapies that enhance the body's natural ability to fight cancer.
